VGHAX
Vanguard Health Care Fund Admiral Shares
1W: -2.6%
1M: -5.6%
3M: -2.5%
YTD: -0.6%
1Y: +7.0%
3Y: +19.8%
5Y: +20.0%
$85.80
-0.22 (-0.26%)
Weekly Expected Move ±2.0%
$83
$84
$86
$88
$89
ETF-Level Metrics
AUM$38.9B
Holdings83
Top 10 Wt41.5%
Beta0.54
% Profitable54%
Coverage97%
Portfolio Valuation
P/E22.8
P/B4.0
P/S3.2
EV/EBITDA15.3
P/FCF26.9
PEG1.38
Profitability & Returns
Gross Margin53.7%
Net Margin13.8%
ROE18.3%
ROA9.9%
ROIC16.7%
Div Yield1.28%
Leverage & Liquidity
Debt/Equity0.28
Debt/Assets0.15
Net Debt/EBITDA0.1x
Interest Cov23.8x
Current Ratio1.95
Quick Ratio1.51
Growth (YoY)
Revenue+24.0%
Net Income+18.2%
EPS+20.0%
FCF+53.8%
EBITDA+22.6%
Rev CAGR 3Y+21.8%
Quality Scores
Piotroski F6.3
Altman Z8.37
IS Quality72.5
IS Overall61.0
IS Value45.5
Median P/E17.4
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 83 | 97.7% | 2.9 |
| Other | 19 | 2.3% | — |
Smart Money Overlap
2 holdings with signals
Showing 50 of 102 holdings
· Page 1 of 3
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | LLY | 8.83% | $3.4B | 2,861,509 | 38.2 | $1.1T | Healthcare |
| 2 | Merck & Co Inc | MRK | 6.05% | $2.4B | 18,306,247 | 114.5 | $356.4B | Healthcare |
| 3 | AstraZeneca PLC | AZN.L | 4.85% | $1.9B | 10,093,801 | 23.4 | $184.1B | Healthcare |
| 4 | Johnson & Johnson | JNJ | 4.50% | $1.7B | 6,886,880 | 29.6 | $617.0B | Healthcare |
| 5 | UnitedHealth Group Inc | UNH | 4.41% | $1.7B | 4,128,127 | 23.9 | $337.7B | Healthcare |
| 6 | GSK PLC | GSK.L | 2.97% | $1.2B | 44,002,585 | 14.8 | $71.3B | Healthcare |
| 7 | CVS Health Corp | CVS | 2.59% | $1.0B | 9,741,345 | 22.6 | $110.3B | Healthcare |
| 8 | Edwards Lifesciences Corp | EW | 2.49% | $966.8M | 10,687,609 | 48.9 | $49.0B | Healthcare |
| 9 | Vertex Pharmaceuticals Inc | VRTX | 2.41% | $938.9M | 1,890,142 | 29.1 | $128.1B | Healthcare |
| 10 | Intuitive Surgical Inc | ISRG | 2.37% | $922.1M | 2,318,800 | 44.3 | $138.5B | Healthcare |
| 11 | Danaher Corp | DHR | 2.37% | $921.3M | 4,836,473 | 37.9 | $150.5B | Healthcare |
| 12 | Argenx SE | ARGX.BR | 2.14% | $832.9M | 898,582 | 33.3 | $50.7B | Healthcare |
| 13 | Cencora Inc | COR | 2.07% | $804.0M | 2,841,020 | 22.9 | $60.1B | Healthcare |
| 14 | Elevance Health Inc | ELV | 1.85% | $718.7M | 1,858,361 | 17.2 | $83.8B | Healthcare |
| 15 | Cardinal Health Inc | CAH | 1.77% | $690.0M | 2,904,627 | 31.4 | $53.5B | Healthcare |
| 16 | Novartis AG | NOVN.SW | 1.77% | $688.7M | 4,406,328 | 21.3 | $221.1B | Healthcare |
| 17 | UCB SA | UCB.BR | 1.72% | $667.5M | 2,229,517 | 17.7 | $38.9B | Healthcare |
| 18 | Regeneron Pharmaceuticals Inc | REGN | 1.66% | $645.0M | 1,034,477 | 17.6 | $75.7B | Healthcare |
| 19 | AbbVie Inc | ABBV | 1.52% | $592.9M | 2,356,112 | 74.0 | $464.3B | Healthcare |
| 20 | HCA Healthcare Inc | HCA | 1.49% | $580.7M | 1,489,270 | 14.2 | $92.4B | Healthcare |
| 21 | Abbott Laboratories | ABT | 1.45% | $564.9M | 6,225,404 | 31.4 | $168.7B | Healthcare |
| 22 | Biogen Inc | BIIB | 1.40% | $545.8M | 2,526,097 | 38.7 | $32.5B | Healthcare |
| 23 | Alnylam Pharmaceuticals Inc | ALNY | 1.36% | $530.3M | 1,761,679 | 36.0 | $29.4B | Healthcare |
| 24 | Agilent Technologies Inc | A | 1.31% | $508.0M | 3,824,222 | 33.0 | $47.4B | Healthcare |
| 25 | Galderma Group AG | GALD.SW | 1.30% | $506.9M | 2,228,631 | 47.4 | $37.4B | Healthcare |
| 26 | Boston Scientific Corp | BSX | 1.24% | $481.1M | 11,271,501 | 17.2 | $63.3B | Healthcare |
| 27 | Roche Holding AG | ROP.SW | 1.09% | $423.4M | 1,029,839 | 22.5 | $275.2B | Healthcare |
| 28 | United Therapeutics Corp | UTHR | 1.05% | $410.0M | 756,630 | 17.9 | $23.0B | Healthcare |
| 29 | NOM TSY FICC 07/01/2026 Private | — | 1.02% | $395.0M | 395,000,000 | — | — | — |
| 30 | Revolution Medicines Inc | RVMD | 1.01% | $392.2M | 2,094,159 | -23.3 | $43.9B | Healthcare |
| 31 | Centene Corp | CNC | 1.01% | $392.0M | 6,106,988 | -6.1 | $31.1B | Healthcare |
| 32 | Dexcom Inc | DXCM | 1.01% | $391.2M | 5,807,970 | 33.0 | $32.2B | Healthcare |
| 33 | Chugai Pharmaceutical Co Ltd | 4519.T | 0.98% | $381.8M | 8,264,744 | 21.1 | $9.9T | Healthcare |
| 34 | Genmab A/S | GMAB.CO | 0.95% | $369.0M | 1,345,944 | 26.5 | $138.6B | Healthcare |
| 35 | Shionogi & Co Ltd | 4507.T | 0.94% | $366.1M | 21,427,449 | 9.0 | $2.4T | Healthcare |
| 36 | Daiichi Sankyo Co Ltd | 4568.T | 0.94% | $364.6M | 22,675,166 | 20.5 | $4.9T | Healthcare |
| 37 | Otsuka Holdings Co Ltd | 4578.T | 0.93% | $361.0M | 5,423,000 | 14.7 | $5.9T | Healthcare |
| 38 | Ionis Pharmaceuticals Inc | IONS | 0.92% | $359.2M | 4,530,677 | -12.6 | $7.2B | Healthcare |
| 39 | Stryker Corp | SYK | 0.88% | $342.3M | 1,087,087 | 28.3 | $105.6B | Healthcare |
| 40 | Medtronic PLC | MDT | 0.85% | $330.8M | 4,228,128 | 21.1 | $110.6B | Healthcare |
| 41 | Thermo Fisher Scientific Inc | TMO | 0.82% | $317.5M | 633,180 | 35.2 | $242.1B | Healthcare |
| 42 | Incyte Corp | INCY | 0.74% | $288.9M | 2,548,668 | 14.2 | $23.4B | Healthcare |
| 43 | Madrigal Pharmaceuticals Inc | MDGL | 0.72% | $280.2M | 521,926 | -38.7 | $11.5B | Healthcare |
| 44 | Ascendis Pharma A/S | ASND | 0.70% | $272.8M | 1,022,832 | 16.7 | $14.2B | Healthcare |
| 45 | Cytokinetics Inc | CYTK | 0.68% | $264.6M | 3,105,916 | -9.1 | $8.2B | Healthcare |
| 46 | Amgen Inc | AMGN | 0.66% | $258.1M | 712,834 | 24.8 | $217.5B | Healthcare |
| 47 | QIAGEN NV | QGEN | 0.66% | $254.7M | 6,514,443 | 22.9 | $9.2B | Healthcare |
| 48 | STERIS PLC | STE | 0.61% | $237.3M | 1,126,852 | 25.4 | $20.3B | Healthcare |
| 49 | ICON PLC | ICLR | 0.56% | $218.3M | 1,256,622 | 37.8 | $12.4B | Healthcare |
| 50 | Kymera Therapeutics Inc | KYMR | 0.53% | $206.0M | 1,796,469 | -33.0 | $8.8B | Healthcare |